KR20210118712A - A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter. - Google Patents

A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter. Download PDF

Info

Publication number
KR20210118712A
KR20210118712A KR1020200035712A KR20200035712A KR20210118712A KR 20210118712 A KR20210118712 A KR 20210118712A KR 1020200035712 A KR1020200035712 A KR 1020200035712A KR 20200035712 A KR20200035712 A KR 20200035712A KR 20210118712 A KR20210118712 A KR 20210118712A
Authority
KR
South Korea
Prior art keywords
hydrogen peroxide
oxygen
hemoglobin
air bubbles
reacting
Prior art date
Application number
KR1020200035712A
Other languages
Korean (ko)
Inventor
석 규 이
이광석
Original Assignee
석 규 이
이광석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 석 규 이, 이광석 filed Critical 석 규 이
Priority to KR1020200035712A priority Critical patent/KR20210118712A/en
Publication of KR20210118712A publication Critical patent/KR20210118712A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention is to save lives by killing bacteria, viruses, and variant viruses that have infected the human body. The present invention relates to a drug system which kills variant viruses by collecting oxygen-containing bubbles (4) generated by reacting edible hydrogen peroxide (2) with hemoglobin in solid matter (1).

Description

식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템{omitted}A drug system that kills a mutant virus that collects oxygen-containing bubbles generated by reacting edible hydrogen peroxide with hemoglobin in a solid material {omitted}

본 발명은 인체에 감염된 세균과 바이러스 및 변종바이러스를 사멸시켜 생명을 구하는 것으로써The present invention saves lives by killing bacteria, viruses, and mutated viruses that have infected the human body.

식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템에 관한 것이다It relates to a drug system that kills a mutant virus that collects oxygen-containing bubbles generated by reacting edible hydrogen peroxide with hemoglobin in a solid material.

본 발명은 인체에 감염된 세균과 바이러스 및 변종바이러스를 사멸시켜 생명을 구하는 것으로The present invention is to save lives by killing bacteria, viruses and mutated viruses that have infected the human body.

종래에는 인체에 감염된 변종바이러스에 대하여 즉시 치료대책이 없는 큰 단점이 있다Conventionally, there is a big disadvantage that there is no immediate treatment measures for the mutant virus that has infected the human body.

본 발명은 상기한 종래의 문제점을 해소하기 위하여The present invention in order to solve the above conventional problems

인체에 감염된 세균과 바이러스 및 변종바이러스를 사멸시켜 생명을 구하는 것으로써,By killing bacteria, viruses and mutated viruses that have infected the human body, it saves lives.

식용과산화수소(2)를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포(4)를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템을 제공 하는데 목적이 있다The purpose of this is to provide a drug system that kills the mutant virus that collects oxygen-containing air bubbles (4) generated by reacting edible hydrogen peroxide (2) with hemoglobin in solid matter.

본 발명은 식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템을 제공하여 목적을 달성한다The present invention achieves the object by providing a pharmaceutical system that kills a mutant virus in which air bubbles containing oxygen generated by reacting edible hydrogen peroxide with hemoglobin are captured in a solid material.

본 발명은 식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템에 관한 것 으로써The present invention relates to a pharmaceutical system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in a solid material.

인체가 세균과 바이러스 및 변종바이러스에 감염되면 본 발명은 즉시 식용과산화수소(2)를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포(4)를 고형물(1)에 포집시킨 변종바이러스를 사멸시키는 약재시스템을 복용하여 인체에 감염된 세균과 바이러스 및 변종바이러스를 사멸시켜 생명을 구하는 큰장점을 도출한다When the human body is infected with bacteria, viruses and mutant viruses, the present invention immediately takes a drug system that kills mutant viruses that collect oxygen-containing air bubbles (4) generated by reacting edible hydrogen peroxide (2) with hemoglobin in the solid (1). It kills bacteria, viruses, and mutated viruses that infect the human body, thereby deriving a great advantage in saving lives.

또한,복용한 식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포(4)를 벌꿀 및 당류(3)의 고형물 (1)을 장기의 위액등과 반응시켜 녹이면서 포집된 산소를 포함한 기포(4)를 장기에 방출하여 변종바이러스를 접촉시켜 변종바이러스의 단백질을 파괴하여 세균과 함께 사멸시키는 큰 장점이 있다In addition, the oxygen-containing bubbles (4) generated by reacting the taken edible hydrogen peroxide with hemoglobin are dissolved by reacting the solids (1) of honey and sugar (3) with the gastric juice of organs, and the bubbles containing oxygen (4) It has a great advantage in that it destroys the protein of the variant virus by releasing the

또한,포집된 산소를 포함한 기포(4)에 잔류하는 식용과산화수소(H202)를 기체화시켜 발생하는 산소를 인체 장기에 물질이동시켜 흡습시키고 용존산소량을 대폭증대시켜 세포의 면역력을 극대화 시키는 기능을 제공하는 큰 장점이 있다 In addition, edible hydrogen peroxide (H 2 0 2 ) remaining in the air bubbles (4) containing the captured oxygen is vaporized, and the oxygen generated by moving the material to the body organs to absorb moisture and greatly increase the amount of dissolved oxygen to maximize the immunity of cells. There is a great advantage of providing the function

또한,감염된 인체의 세균과 바이러스를 외부로 유출되지 않도록 사멸시켜 질병전파를 탁월하게 차단하는 효과를 도출시켜 제공하는 큰 장점이 있다In addition, there is a great advantage of providing the effect of excellently blocking disease transmission by killing infected bacteria and viruses so that they do not leak to the outside.

또한,제조코스트가 저렴한 큰 장점이 있다In addition, it has the great advantage of low manufacturing cost.

도1은 본 발명의 따른, 식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
을 개략적으로 도시한 구조도
※ 도면의 주요 부분에 부호의 설명
1: 고형물 2: 식용과산화수소
3: 천연미네랄과 전분, 벌꿀 및 당류 4: 산소를 포함한 기포
5:살균된 헤모글로빈으로 이루어진 가축의 혈액
1 is a pharmaceutical system for killing a mutant virus that captures oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in a solid according to the present invention;
A schematic diagram of the
※ Explanation of symbols in the main parts of the drawing
1: Solids 2: Edible hydrogen peroxide
3: Natural minerals and starch, honey and sugar 4: Bubbles containing oxygen
5: Livestock blood consisting of sterilized hemoglobin

이하, 첨부된 도면을 참조하여 본 발명을 한정하지 않는 바람직한 실시예를 상세히 설명한다.Hereinafter, preferred embodiments without limiting the present invention will be described in detail with reference to the accompanying drawings.

도1은 본 발명은 식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템을 개략적으로 도시한 구조도이고,1 is a structural diagram schematically showing a drug system that kills a mutant virus that captures oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in a solid;

"구체적으로 살펴보면 아래와 같다."“If you look at it in detail, it is as follows.”

본 발명의 제조단계를 나열하자면Let's list the manufacturing steps of the present invention

첫째, 중량대비 5%이하의 천연미네랄과 전분, 벌꿀 및 당류(3)를 중량대비 85%이상과 혼재하여 섭씨100도 이하로 지속적으로 저으면서 끓이는 단계와First, 5% or less of natural minerals by weight, starch, honey, and sugars (3) are mixed with 85% or more by weight and boiled while stirring continuously at 100 degrees Celsius or less.

둘째, 살균된 헤모글로빈으로 이루어진 가축의 혈액(5)을 중량대비 7% 이하와 식용과산화수소(2)3%이하를 혼재하여 반응시켜 산소를 포함한 기포(4)를 발생시키는 단계후Second, after the step of reacting livestock blood (5) made of sterilized hemoglobin in a mixture of 7% or less and edible hydrogen peroxide (2) 3% or less by weight to generate oxygen-containing air bubbles (4).

셋째, 둘째 단계에서 이루어지는 헤모글로빈으로 이루어진 가축의 혈액을 중량대비 7% 이하와 식용과산화수소3%이하를 혼재하여 반응시켜 산소를 포함한 기포(4)가 발생하는 것을Third, the generation of oxygen-containing air bubbles (4) by reacting the blood of livestock made of hemoglobin in the second step with 7% or less and 3% or less of edible hydrogen peroxide by weight.

첫째단계의 중량대비 5%이하의 천연미네랄과 전분, 벌꿀 및 당류(3)를 중량대비85%이상과 혼재하여 섭씨100도 이하로 지속적으로 저으면서 끓이는 곳에 혼재하여 천연미네랄과 전분,벌꿀 및 당류(3)의 끈적한 점성을 이용하여 식용과산화수소(2)3%이하를 혼재하여 반응시켜 발생하는 산소를 포함한 기포(4)를 가두어 포집하여In the first stage, 5% or less of natural minerals, starch, honey, and sugars (3) are mixed with 85% or more of the weight by weight, and mixed with natural minerals, starch, honey and sugars ( By using the sticky viscosity of 3), it traps and collects air bubbles (4) containing oxygen generated by mixing and reacting with edible hydrogen peroxide (2) 3% or less.

경구투여시에 폭발적으로 단시간에 반응하는 위험한 식용과산화수소를 법제하여 폭발적으로 반응하는것을 제거하고 1차반응하여 발생된 식용과산화수소(2)의 산소를 포함한 기포(4)를 천연미네랄과 전분, 벌꿀 및 당류(3)의 끈적한 점성을 이용하여 가두어 경구투여시에 피부와 세포에 직접접촉하지 않고 서서히 산소기포를 방출하여 변종바이러스를 사멸 시키도록Eliminate the explosive reaction by legislating dangerous edible hydrogen peroxide that reacts explosively in a short period of time during oral administration By using the sticky viscosity of the sugar (3), it is confined so that, when administered orally, oxygen bubbles are gradually released without direct contact with the skin and cells to kill the variant virus.

액상의 천연미네랄과 전분, 벌꿀 및 당류(3)를 서서히 식히면서 고형물(1)로 고형화시켜 과립형태 또는 아이스크림 형태 또는 젤리형태로 만들어서 제조하여 포장하는 단계로 제조 한 것이다Liquid natural minerals, starch, honey, and sugars (3) are slowly cooled and solidified into a solid (1), which is then made into granules, ice cream, or jelly, and manufactured and packaged.

또한,본발명은 기체화되어 발생하는 산소를 인체 장기에 물질이동시켜 흡습시키고 용존산소량을 대폭증대시켜 세포의 면역력을 극대화 시키는 기능과 전분, 벌꿀 및 당류(3)를 중량대비85%이상과 혼재하여 내복하여 투여 됨 으로써In addition, the present invention has the function of maximizing the immunity of cells by moving the oxygen generated by gasification into the body organs to absorb moisture and greatly increasing the amount of dissolved oxygen, and starch, honey and sugar (3) are mixed with 85% or more by weight and administered orally

세포의 염증물질을 전분, 벌꿀 및 당류(3)쪽으로 물질이동 시키면서 염증을 포집하고It captures inflammation while moving the inflammatory substances in the cells toward starch, honey and sugars (3).

세포의 수분을 흡습하면서 세포를 소프트하게 연질로 응축시켜 세포의 문을 닫아 세균이나 변종바이러스 침투를 억제하면서While absorbing moisture from the cells, the cells are softly condensed to close the cell door to suppress the penetration of bacteria or mutated viruses.

장기내 상처를 보호 하고 세포의 2차감염을 탁월하게 방지하는 기능과The function of protecting internal wounds and excellently preventing secondary infection of cells and

천연미네랄과 전분, 벌꿀 및 당류(3)에 포집되어 잔류하는 식용과산화수소(2)의 성분을 장기내의 분비물에 서서히 방출하면서 산소를 포함한 기포(4)를 발생시켜By gradually releasing the components of edible hydrogen peroxide (2) that remain captured in natural minerals, starch, honey and sugars (3) to the secretions in the organs, air bubbles (4) containing oxygen are generated.

세균이나 변종바이러스의 단백질을 파괴하여 변종바이러스 활동할 수 없는 조건을 제시하여 사멸시키는 기능과 동시에 발생된 산소는 폐를 비롯한 호흡기에 자연분산 공급시켜 생명을 구하는 기능으로 이루어지며 사멸된 세균이나 변종바이러스는 대변과 소변으로 방출시키는 것을 특징으로 하는It has the function of destroying the protein of bacteria or strain virus by presenting conditions in which the strain virus cannot work, and also has a function to save lives by supplying oxygen generated at the same time to the respiratory tract including the lungs. characterized by excretion in feces and urine

식용과산화수소(2)를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포(4)를 고형물(1)에 포집시킨 변종바이러스를 사멸시키는 약재시스템 이다It is a drug system that kills the mutant virus that collects oxygen-containing bubbles (4) generated by reacting edible hydrogen peroxide (2) with hemoglobin in the solid (1).

또한, 본 발명은 청구범위 요지를 벗어나지 않은 범위내에서In addition, the present invention is provided within the scope without departing from the scope of the claims.

유해가스흡착과 전착기능의 고령토, 2차점토, 볼클레이, 카오린,벤토나이트 등의 광물을 미량 첨가 할 수 있고 고형화시킨뒤 분말로 제조되는 것을 포함하고Minerals such as kaolin, secondary clay, ball clay, kaolin, bentonite, etc., which have the function of adsorption of harmful gas and electrodeposition, can be added in trace amounts and are made into powder after being solidified.

어느 한 종류에 한정하지 않고 변이되며 살균이 필요한 필요용도에 따라 다종류의 약전이 적용되는 것이고 친환경 향기와 영양제와 부수적인 원적외선 방출기능 및 기타기능이 추가 될 수 있다It is not limited to any one type, but various types of pharmacopoeia are applied depending on the necessary use requiring sterilization, and eco-friendly fragrances and nutrients, incidental far-infrared emission function and other functions can be added.

Claims (6)

본 발명은 인체에 감염된 세균과 바이러스 및 변종바이러스를 사멸시켜 생명을 구하는 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The present invention is characterized in that it saves lives by killing bacteria, viruses and mutated viruses that have infected the human body.
A drug system that kills the mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solids;
제1항에 있어서
첫째, 중량대비 5%이하의 천연미네랄과 전분, 벌꿀 및 당류(3)를 중량대비85%이상과 혼재하여 섭씨100도 이하로 지속적으로 저으면서 끓이는 단계와
둘째, 살균된 헤모글로빈으로 이루어진 가축의 혈액(5)을 중량대비 7% 이하와 식용과산화수소(2)3%이하를 혼재하여 반응시켜 산소를 포함한 기포(4)를 발생시키는 단계후
셋째, 둘째 단계에서 이루어지는 헤모글로빈으로 이루어진 가축의 혈액을 중량대비 7% 이하와 식용과산화수소3%이하를 혼재하여 반응시켜 산소를 포함한 기포(4)가 발생하는 것을
첫째단계의 중량대비 5%이하의 천연미네랄과 전분, 벌꿀 및 당류(3)를 중량대비85%이상과 혼재하여 섭씨100도 이하로 지속적으로 저으면서 끓이는 곳에 혼재하여 천연미네랄과 전분, 벌꿀 및 당류(3)의 끈적한 점성을 이용하여 식용과산화수소(2)3%이하를 혼재하여 반응시켜 발생하는 산소를 포함한 기포(4)를 가두어 포집하여
경구투여시에 폭발적으로 단시간에 반응하는 위험한 식용과산화수소를 법제하여 폭발적으로 반응하는것을 제거하고 1차반응하여 발생된 식용과산화수소(2)의 산소를 포함한 기포(4)를 천연미네랄과 전분, 벌꿀 및 당류(3)의 끈적한 점성을 이용하여 가두어 경구투여시에 피부와 세포에 직접접촉하지 않고 서서히 산소기포를 방출하여 변종바이러스를 사멸 시키도록
액상의 천연미네랄과 전분, 벌꿀 및 당류(3)를 서서히 식히면서 고형물(1)로 고형화시켜 과립형태 또는 아이스크림 형태 또는 젤리형태로 만들어서 제조하여 포장하는 단계로 제조 한 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The method of claim 1
First, 5% or less of natural minerals by weight, starch, honey, and sugar (3) are mixed with 85% or more by weight and boiled while stirring continuously at 100 degrees Celsius or less;
Second, after the step of reacting livestock blood (5) made of sterilized hemoglobin in a mixture of 7% or less and edible hydrogen peroxide (2) 3% or less by weight to generate oxygen-containing air bubbles (4).
Third, the generation of oxygen-containing air bubbles (4) by reacting the blood of livestock made of hemoglobin in the second step with 7% or less and 3% or less of edible hydrogen peroxide by weight.
In the first stage, 5% or less of natural minerals, starch, honey, and sugars (3) are mixed with 85% or more by weight, and mixed with natural minerals, starch, honey and sugars ( 3) By using the sticky viscosity of
Eliminate the explosive reaction by legislating dangerous edible hydrogen peroxide that reacts explosively in a short period of time during oral administration Contained using the sticky viscosity of the saccharide (3), when administered orally, oxygen bubbles are gradually released without direct contact with the skin and cells to kill the variant virus.
It is characterized in that the liquid natural minerals, starch, honey, and sugars (3) are cooled slowly and solidified into a solid (1) to form granules or ice cream or jelly, manufactured and packaged.
A drug system that kills the mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solids;
제1항에 있어서
기체화되어 발생하는 산소를 인체 장기에 물질이동시켜 흡습시키고 용존산소량을 대폭증대시켜 세포의 면역력을 극대화 시키는 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The method of claim 1
It is characterized by maximizing the immunity of cells by moving the oxygen generated by gasification to the human body to absorb moisture and greatly increasing the amount of dissolved oxygen.
A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solids;
제1항에 있어서
세포의 염증물질을 전분, 벌꿀 및 당류(3)쪽으로 물질이동 시키면서 염증을 포집하고
세포의 수분을 흡습하면서 세포를 소프트하게 연질로 응축시켜 세포의 문을 닫아 세균이나 변종바이러스 침투를 억제하면서
장기내 상처를 보호 하고 세포의 2차감염을 방지하는 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The method of claim 1
It captures inflammation while moving the inflammatory substances in the cells toward starch, honey and sugars (3).
While absorbing moisture from the cells, the cells are softly condensed to close the cell door to suppress the penetration of bacteria or mutated viruses.
It is characterized in that it protects internal wounds and prevents secondary infection of cells.
A drug system that kills the mutant virus that collects air bubbles generated by reacting edible hydrogen peroxide with hemoglobin,
제1항에 있어서
천연미네랄과 전분, 벌꿀 및 당류(3)에 포집되어 잔류하는 식용과산화수소(2)의 성분을 장기내의 분비물에 서서히 방출하면서 산소를 포함한 기포(4)를 발생시켜
세균이나 변종바이러스의 단백질을 파괴하여 변종바이러스 활동할 수 없는 조건을 제시하여 사멸시키는 기능과 동시에 발생된 산소는 폐를 비롯한 호흡기에 자연분산 공급시켜 생명을 구하는 기능으로 이루어 진 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The method of claim 1
By gradually releasing the components of edible hydrogen peroxide (2) that remain captured in natural minerals, starch, honey and sugars (3) to the secretions in the organs, air bubbles (4) containing oxygen are generated.
It is characterized by the function of destroying the proteins of bacteria or strain viruses by presenting conditions in which the strain virus cannot act and killing them, as well as the function of saving lives by supplying oxygen generated at the same time to the respiratory tract including the lungs.
A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solids;
제1항에 있어서
사멸된 세균이나 변종바이러스는 대변과 소변으로 방출시키는 것을 특징으로 한
식용과산화수소를 헤모글로빈에 반응시켜 발생한 산소를 포함한 기포를 고형물에 포집시킨 변종바이러스를 사멸시키는 약재시스템,
The method of claim 1
It is characterized in that the killed bacteria or mutated virus are released in feces and urine.
A drug system that kills the mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solids;
KR1020200035712A 2020-03-23 2020-03-23 A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter. KR20210118712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200035712A KR20210118712A (en) 2020-03-23 2020-03-23 A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200035712A KR20210118712A (en) 2020-03-23 2020-03-23 A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter.

Publications (1)

Publication Number Publication Date
KR20210118712A true KR20210118712A (en) 2021-10-01

Family

ID=78609776

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200035712A KR20210118712A (en) 2020-03-23 2020-03-23 A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter.

Country Status (1)

Country Link
KR (1) KR20210118712A (en)

Similar Documents

Publication Publication Date Title
Molan Why honey is effective as a medicine: 2. The scientific explanation of its effects
CN103108643B (en) Comprise the antibacterial of peroxide, alcohol and chelating agen
CN104306981B (en) Preparation method of anti Helicobacter pylori active antibacterial peptide gastric mucosa nanoparticle delivery system
Abdurrazaq et al. Cervical necrotizing fasciitis: a potentially fatal disease with varied etiology
Dun Veterinary Medicines Their Actions and Uses
Mohr et al. Actinomycosis treated with lincomycin
CN1312080A (en) Composition containing fatty acid
KR20210118712A (en) A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter.
CN102100687B (en) Application of medicine composition with function of exterminating oral helicobacter pylori
CN100408041C (en) Medicine composition for treating valval and/or vaginal infection
Batson et al. Acute mercury poisoning: treatment with BAL and in anuric states with continuous peritoneal lavage
CN105726491A (en) Polyhexamethylene guanidine medicine for treating stomach disease and preparation method and application thereof
WO2017060821A1 (en) Hemostatic composition
EA010241B1 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of vaginal fungal infections
CN105168629A (en) Traditional Chinese medicine gel for treating qi-stagnation and blood stasis type decubitus
Sekhon Iodine: A support against infections and emerging as an antibiotic.
KR20210117783A (en) Edible hydrogen peroxide drug system that kills strained viruses that have infected the human body
CN109908205A (en) A kind of drug prevented or treat mouth disease
Choi et al. Effect of bee venom treatment in sows with oligogalactic syndrome postpartum
CN1529606A (en) Preparation containing seleniter or selenate for treating wound
CN102000282B (en) Pure traditional Chinese medicine paster for treating recurrent oral ulcer and preparation method thereof
CN1110306C (en) High effect mycin powder injection
KR20210120761A (en) A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide
Kreft, E. & Amihood Sporotrichosis of the knee joint
RU2291690C2 (en) Pharmaceutical anti-herpetic composition